Company Filing History:
Years Active: 2017-2025
Title: Chris Lloyd: Innovator in Amyloid Beta Research
Introduction
Chris Lloyd is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies targeting amyloid beta peptides. With a total of 5 patents to his name, Lloyd's work is pivotal in addressing conditions associated with amyloidosis, including Alzheimer's disease.
Latest Patents
Lloyd's latest patents focus on antibodies to human amyloid beta. One of his key inventions is an antibody that selectively binds to the human amyloid beta 42 peptide over the human amyloid beta 40 peptide. These antibodies are designed as therapeutic agents for binding amyloid beta 42 peptides, which play a crucial role in the treatment of conditions related to amyloidosis, such as Alzheimer's disease.
Career Highlights
Chris Lloyd is currently associated with Medimmune Limited, where he continues to advance his research in antibody development. His innovative work has positioned him as a leading figure in the fight against neurodegenerative diseases.
Collaborations
Lloyd collaborates with talented professionals in his field, including Maria Groves and Suzanne Gustavsson. Their combined expertise enhances the research efforts at Medimmune Limited.
Conclusion
Chris Lloyd's contributions to the field of amyloid beta research are invaluable. His innovative patents and collaborative efforts are paving the way for new therapeutic approaches to combat Alzheimer's disease and other related conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.